Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains.
Authors
Holmes, OPillozzi, S
Deakin, Jon A
Carafoli, F
Kemp, L
Butler, P J G
Lyon, Malcolm
Gherardi, Ermanno
Affiliation
MRC Centre, Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK.Issue Date
2007-03-23
Metadata
Show full item recordAbstract
Hepatocyte growth factor/scatter factor (HGF/SF), the ligand for the receptor tyrosine kinase encoded by the c-Met proto-oncogene, is a multidomain protein structurally related to the pro-enzyme plasminogen and with major roles in development, tissue regeneration and cancer. We have expressed the N-terminal (N) domain, the four kringle domains (K1 to K4) and the serine proteinase homology domain (SP) of HGF/SF individually in yeast or mammalian cells and studied their ability to: (i) bind the Met receptor as well as heparan sulphate and dermatan sulphate co-receptors, (ii) activate Met in target cells and, (iii) map their binding sites onto the beta-propeller domain of Met. The N, K1 and SP domains bound Met directly with comparable affinities (K(d)=2.4, 3.3 and 1.4 microM). The same domains also bound heparin with decreasing affinities (N>K1>>SP) but only the N domain bound dermatan sulphate. Three kringle domains (K1, K2 and K4) displayed agonistic activity on target cells. In contrast, the N and SP domains, although capable of Met binding, displayed no or little activity. Further, cross-linking experiments demonstrated that both the N domain and kringles 1-2 bind the beta-chain moiety (amino acid residues 308-514) of the Met beta-propeller. In summary, the K1, K2 and K4 domains of HGF/SF are sufficient for Met activation, whereas the N and SP domains are not, although the latter domains contribute additional binding sites necessary for receptor activation by full length HGF/SF. The results provide new insights into the structure/function of HGF/SF and a basis for engineering the N and K1 domains as receptor antagonists for cancer therapy.Citation
Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains. 2007, 367 (2):395-408 J. Mol. Biol.Journal
Journal of Molecular BiologyDOI
10.1016/j.jmb.2006.12.061PubMed ID
17258232Type
ArticleLanguage
enISSN
0022-2836ae974a485f413a2113503eed53cd6c53
10.1016/j.jmb.2006.12.061
Scopus Count
Collections
Related articles
- Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
- Authors: Mizuno K, Inoue H, Hagiya M, Shimizu S, Nose T, Shimohigashi Y, Nakamura T
- Issue date: 1994 Jan 14
- Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
- Authors: Donate LE, Gherardi E, Srinivasan N, Sowdhamini R, Aparicio S, Blundell TL
- Issue date: 1994 Dec
- Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
- Authors: Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguchi K, Wingfield PT, Rubin JS
- Issue date: 1997 Apr 4
- Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.
- Authors: Hartmann G, Prospero T, Brinkmann V, Ozcelik C, Winter G, Hepple J, Batley S, Bladt F, Sachs M, Birchmeier C, Birchmeier W, Gherardi E
- Issue date: 1998 Jan 29
- Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
- Authors: Rubin JS, Day RM, Breckenridge D, Atabey N, Taylor WG, Stahl SJ, Wingfield PT, Kaufman JD, Schwall R, Bottaro DP
- Issue date: 2001 Aug 31